Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply.

Dyfrig Hughes; Giovanna Culeddu; Catrin Plumpton; Eifiona Wood; Andrew D. Dick; Michael W. Beresford; Athimalaipet V.  Ramanan

doi:10.1016/j.ophtha.2018.12.005

Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply.

Dyfrig Hughes
, Giovanna Culeddu
, Catrin Plumpton
, Eifiona Wood
, Andrew D. Dick
, Michael W. Beresford
, Athimalaipet V. Ramanan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e24-e25
Journal	Ophthalmology
Volume	126
Issue number	3
Early online date	22 Feb 2019
DOIs	https://doi.org/10.1016/j.ophtha.2018.12.005
Publication status	Published - Mar 2019

Access to Document

10.1016/j.ophtha.2018.12.005

Cite this

@article{448709201b0e45dd9e7407a5c845bff6,

title = "Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors{\textquoteright} reply.",

author = "Dyfrig Hughes and Giovanna Culeddu and Catrin Plumpton and Eifiona Wood and Dick, \{Andrew D.\} and Beresford, \{Michael W.\} and Ramanan, \{Athimalaipet V.\}",

year = "2019",

month = mar,

doi = "10.1016/j.ophtha.2018.12.005",

language = "English",

volume = "126",

pages = "e24--e25",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply.

AU - Hughes, Dyfrig

AU - Culeddu, Giovanna

AU - Plumpton, Catrin

AU - Wood, Eifiona

AU - Dick, Andrew D.

AU - Beresford, Michael W.

AU - Ramanan, Athimalaipet V.

PY - 2019/3

Y1 - 2019/3

U2 - 10.1016/j.ophtha.2018.12.005

DO - 10.1016/j.ophtha.2018.12.005

M3 - Letter

SN - 0161-6420

VL - 126

SP - e24-e25

JO - Ophthalmology

JF - Ophthalmology

IS - 3

ER -